Blue Trust’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Blue Trust's ADPT Position: Q3 2026 in Review
Blue Trust opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 11 shares worth $319. The stake represents ﹤0.01% of the portfolio and ranks #2327 among its holdings. This is a return to the name: Blue Trust previously reported a position in ADPT as recently as Q2 2025.
Blue Trust first reported a position in ADPT in Q3 2022 and has held it in 6 quarters since. The position peaked at $2K in Q4 2023. 252 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Blue Trust held 11 shares of Adaptive Biotechnologies worth $319 as of Q3 2026.
- Adaptive Biotechnologies was a new Blue Trust position in Q3 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2327 holding.
- Blue Trust first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 6 quarters since.
- Blue Trust's Adaptive Biotechnologies position peaked at $2K in Q4 2023.
- 252 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.